Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter study

✍ Scribed by Deng, Ting; Zhang, Le; Liu, Xiao-jian; Xu, Jian-ming; Bai, Yu-xian; Wang, Yan; Han, Yu; Li, Yu-hong; Ba, Yi

• Book ID: 121599381
• Publisher: Springer US
• Year: 2013
• Tongue: English
• Weight: 199 KB
• Volume: 30
• Category: Article
• ISSN: 1357-0560
• DOI: 10.1007/s12032-013-0752-z